HTR4 and Alzheimer disease: Here, we focus mainly on well-established and incipient AD therapeutic targets, AChE, BuChE, MAOs, β-amyloid deposition, 5-HT4, and serotonin transporter, intending to shed light on new insights in AD multi-target therapy.